U.S. Reduced HIV Funding for Global Programs
The U.S. cut medical aid for HIV programs globally under the Make America Great Again policy during 2025.
Updated on Oct. 5, 2026 in Sexual Health
Live Poll
Should wealthy nations prioritize sustained funding for global health programs during domestic policy shifts?
In 2025, the United States reduced financial support for the President's Emergency Plan for AIDS Relief (PEPFAR) program, impacting international HIV efforts. This policy shift led to decreased funding for prevention awareness campaigns and reduced supplies of condoms and lubricants.
Why it matters
The reduction in U.S. financial support forces countries to overhaul their public health infrastructure and increase domestic efforts to sustain essential medical services. The shift highlights the volatility of international health programs dependent on shifting national policies.
PEPFAR previously provided 50% of HIV medication funding in Rwanda during the 2023-2024 period. While pre-exposure prophylaxis availability declined, patients in Huye have reported consistent access to antiretroviral medication.
The players
PEPFAR
The President's Emergency Plan for AIDS Relief is a U.S. governmental initiative designed to address the global HIV/AIDS epidemic.
USAID
The United States Agency for International Development is responsible for the administration of civilian foreign aid and development assistance.
RBC
The Rwanda Biomedical Centre serves as the primary implementing agency for health care programs and disease management in Rwanda.
The details
The funding reductions followed the implementation of the Make America Great Again policy, which led to USAID stopping operations in various African countries. Consequently, the Rwanda NGO Forum reported a decline in the availability of HIV prevention supplies, particularly among youth, as resources for awareness campaigns were slashed.
Timeline
PEPFAR provided approximately 50 percent of HIV medication funding in Rwanda during 2023-2024.
A Rwanda Biomedical Centre (RBC) official confirmed sufficient HIV medication supply in November 2025.
Analysis regarding the impact of PEPFAR funding reductions was published in 2026.
Health Landscape
The policy shift reflects a fundamental change in the funding model of the President's Emergency Plan for AIDS Relief (PEPFAR) relative to its historical mandate. This funding reduction marks a significant departure from the sustained investment pattern that previously defined global HIV prevention programs.
The funding shortfall necessitates that affected nations, such as Rwanda, ramp up domestic efforts to maintain antiretroviral drug supplies. While some patients still report access to medication, the decline in preventative tools like condoms and lubricants creates new challenges for public health.
The takeaway
The transition toward domestic HIV medication capacity indicates a shift toward nationalized healthcare sustainability in the face of fluctuating foreign aid. Nations now must prioritize internal resource allocation to buffer against the unpredictability of international funding commitments.
Further reading
Learn more about global initiatives on the Sexual Health page.
Source note: This article includes information reported by Taarifa Rwanda Kinyarwanda Version |.
Live Poll
Should wealthy nations prioritize sustained funding for global health programs during domestic policy shifts?
